UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025659 |
|---|---|
| Receipt number | R000029517 |
| Scientific Title | A multicenter, single-arm, phase II study of ramucirumab plus FOLFIRI with 150 mg/m2 irinotecan, standard Nippon dose, as the second-line treatment for Japanese patients with metastatic colorectal cancer |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2018/01/29 10:53:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/01/13 11:37:36 | ||
| 2 | Update | 2017/01/13 12:53:23 | Key secondary outcomes |
|
| 3 | Update | 2017/02/06 21:40:47 | Study type Basic design Randomization Blinding Control No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 |
|
| 4 | Update | 2017/02/06 21:45:41 | Organization Organization Organization Category of Funding Organization |
|
| 5 | Update | 2017/02/06 21:49:19 | Organization Organization Category of Funding Organization |
|
| 6 | Update | 2017/03/13 17:13:37 | Public title Acronym Acronym |
|
| 7 | Update | 2017/06/29 19:45:39 | Date of protocol fixation Anticipated trial start date |
|
| 8 | Update | 2017/06/29 19:50:37 | Organization Organization Organization Category of Funding Organization Research ethics review |
|
| 9 | Update | 2018/01/29 10:53:03 | Recruitment status |
